Patent · US Active

Quinazolinone derivatives for use in the treatment of chlamydiales infections

US9598406B2 · kind B2 · utility

1Cited by

0References

13Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Daniel Gillet · Paris, FR
Julien Barbier · San Francisco, US
Jean-Christophe Cintrat · Igny, FR
Karen Hinsinger · Massy, FR
Thomas Rudel · Berlin, DE
Jo-Ana Herweg · Coburg, DE
Annette Fischer · Würzburg, DE

Key dates

Filing date	Apr 20, 2016
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Apr 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for treating a Chlamydiae infection comprising the administration of a therapeutically effective amount of a compound of formula (I) to a subject in need thereof:Wherein, R1, R2, R3, R4 and p are as defined in claim 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.